We are pleased to announce that Dr. Ashlee Earl is the second keynote for SCS2014! Dr. Earl is a Research Scientist and Group Leader of Bacterial Genomics at the Broad Institute of MIT & Harvard. She received her Ph.D. in Microbiology from Louisiana State University and postdoctoral training from Harvard Medical School with Dr. Roberto Kolter. Having combined genomics and experimental data throughout her studies of bacterial evolution and physiology, Dr. Earl joined the Broad Institute to more directly apply genomics to the improvement of human health.
At Broad, Dr. Earl has led development and analytical efforts for a portfolio of large, collaborative bacterial genomics projects associated with the Human Microbiome Project (HMP), and the NIAID-funded Genome Sequencing Center for Infectious Disease (GSCID). She chaired the Single Cell and Reference Genome Working Groups for the HMP, and led the comparative analysis and publication that established priorities for selecting the "most wanted bacteria" from the human body for sequencing. For GSCID, Dr. Earl oversees more than a dozen projects that involve methods development, sequencing, and analysis of over 10,000 bacterial isolates. These projects include the EnteroGenome Project, to understand the emergence of multiple drug resistance within enterococci by sequencing and analyzing 400 commensal and hospital-adapted strains, and the Tuberculosis Antibiotic Resistance Catalog Project, to describe the genetics of drug resistance from sequencing and analyzing over 2,000 globally-acquired strains of Mycobacterium tuberculosis. Dr. Earl, together with her team of computational scientists, anticipate that these analyses will lead to major advances in health.